All sponsors

MAXVAX Biotechnology Limited Liability Company

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-19
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING1
READOUTS ≤12 MONTHS0
Open MAXVAX Biotechnology Limited Liability Company on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine
NCT05621655
P2Active, not recruitingRotavirus Infections; Rotavirus Gastroenteritis15122023-04-29
Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(low dose)
NCT06642558
P1/2Active, not recruitingRespiratory Syncytial Virus (RSV)5222025-06-30
Recombinant Zoster Vaccine (CHO Cell)
NCT06447779
P3Active, not recruitingHerpes Zoster250002026-03-29 (+7 mo)
Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)
NCT07272434
P3RecruitingRespiratory Syncytial Virus (RSV)250002026-07-31
Recombinant Zoster Vaccine (CHO Cell)
NCT07293065
P3Active, not recruitingHerpes Zoster120002027-12-31